A.V. Tsareva
Research Subjects
A.V. Tsareva has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- D. Yu. Salnikov
Saint-Petersburg State Pediatric Medical University
1 shared publication - Igor A. Shaderkin
I.M. Sechenov First Moscow State Medical University (Sechenov University)
1 shared publication - K. A. Sokolov
Alceya, LLC, Moscow
1 shared publication - Khalid S. Ibishev
Rostov State Medical University
1 shared publication - Natalya A. Nashivochnikova
Privolzhsky Research Medical University
1 shared publication - Nikita Dmitrievich Kubin
Saint Petersburg State University
1 shared publication
Latest Publications
- 1 January 2026
- Published by Geotar-Media Publishing Group in Problems of Nutrition
- Vol. 95 (3)
The role of indole-3-carbinol and epigallocatechin-3-gallate in maintaining men’s health (a systematic literature review)
- 1 January 2026
- Published by Geotar-Media Publishing Group in Problems of Nutrition
- Vol. 95 (3)
The role of indole-3-carbinol and epigallocatechin-3-gallate in maintaining men’s health (a systematic literature review)
- Open Access
- 25 March 2024
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 17 (1)
The search for alternative therapy for chronic cystitis: results of a prospective comparative randomized study on the effectiveness of a biologically active complex «Cystalis® D Plus».
Introduction. Cystitis is one of the most prevalent urinary tract infection (UTI) type. An important specifity of cystitis is the tendency to relapse and chronization of the disease. The search for a
- 25 March 2024
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 17 (1)
Open AccessThe search for alternative therapy for chronic cystitis: results of a prospective comparative randomized study on the effectiveness of a biologically active complex «Cystalis® D Plus».
Introduction. Cystitis is one of the most prevalent urinary tract infection (UTI) type. An important specifity of cystitis is the tendency to relapse and chronization of the disease. The search for a
- Open Access
- 25 September 2023
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 16 (3)
Leukoplakia of the bladder – does this diagnosis have a place in the era of evidencebased medicine?
Over the past 15 years, the clinical diagnosis of «leukoplakia of the bladder» has become a frequently used diagnosis among outpatient and inpatient urologists. But how valid is it, what pathology does it describe and what are we treating? Most often it is established in patients with recurrent lower urinary tract infection (rLUTI), long-term dysuric disorders or chronic pelvic pain syndrome (CPPS). In most cases, it serves as a kind of «last resort» for the practitioner to find finally the cause of persistent complaints of the patient. In this «clinical trash» is thrown all that can potentially be associated with the bladder and is not treated by standard methods defined by clinical guidelines and generally accepted algorithms. At the same time, these are complex patients with a long history and multifactorial pathogenesis, requiring careful examination and thoughtful personalized approaches to treatment. Only such an attitude to the problem makes it possible to find the true cause of the patient's complaints. To date, the questions of the origin and treatment of patients with «leukoplakia of the bladder» remain very controversial. Unfortunately, the lack of knowledge in this matter often serves as a reason for unfair speculations and unjustified surgical activity. The data collected in this article should help practicing physicians to take a more sober look at the problem of «leukoplakia of the bladder» and learn how to help complex patients with persistent dysuria and chronic pelvic pain.
- 25 September 2023
- Published by UroMedia LLC in Experimental and Сlinical Urology
- Vol. 16 (3)
Open AccessLeukoplakia of the bladder – does this diagnosis have a place in the era of evidencebased medicine?
Over the past 15 years, the clinical diagnosis of «leukoplakia of the bladder» has become a frequently used diagnosis among outpatient and inpatient urologists. But how valid is it, what pathology does it describe and what are we treating? Most often it is established in patients with recurrent lower urinary tract infection (rLUTI), long-term dysuric disorders or chronic pelvic pain syndrome (CPPS). In most cases, it serves as a kind of «last resort» for the practitioner to find finally the cause of persistent complaints of the patient. In this «clinical trash» is thrown all that can potentially be associated with the bladder and is not treated by standard methods defined by clinical guidelines and generally accepted algorithms. At the same time, these are complex patients with a long history and multifactorial pathogenesis, requiring careful examination and thoughtful personalized approaches to treatment. Only such an attitude to the problem makes it possible to find the true cause of the patient's complaints. To date, the questions of the origin and treatment of patients with «leukoplakia of the bladder» remain very controversial. Unfortunately, the lack of knowledge in this matter often serves as a reason for unfair speculations and unjustified surgical activity. The data collected in this article should help practicing physicians to take a more sober look at the problem of «leukoplakia of the bladder» and learn how to help complex patients with persistent dysuria and chronic pelvic pain.